维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="Moore PB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	U2504 determines the species specificity of the A- site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome显示文摘	Gurel G Blaha G Moore PB	2009	J Mol Bioi2009，7，：	1
2	Physiopathology of H3-receptors and pharmacology of betahistine acta dtoparyngol显示文摘	Van Cauwenberge PB De Moor SEG	1997	Stockh1997，，：	1
3	Absorption of aluminium-26 in Alzheimer's disease,measured using accelerator mass spectrometry 显示文摘	Moore PB Day JP Taylor GA	2000	Dement Geriatr Cogn Disord2000，11，2：	1
4	Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance 显示文摘	Tu D Blaha G Moore PB	2005	Cell2005，121，2：	1
5	Physiopathollgy of H3 receptors and pharmacology of Betahistine显示文摘	Van Cauwenberge PB De Moor SEG	1997	Acta Otolaryngol ( Stock)1997，，：	1
6	Hepatocellular carci- noma in children显示文摘	Moore SW Hesseling PB Wessels G	1997	Pediatr Surg Int1997，12，：	1
7	Absorption of aluminum - 26 in Alzheimer's disease, measured using accelerator mass spectrometry显示文摘	Moore PB Day JP Taylor GA	2000	Dement Geriatr Cogn Disord2000，11，2：	1
8	Absorption of aluminium 26 in Alzheimers disease, measured using accelerator mass spectrometry显示文摘	Moore PB Day JP Taylor GA	2000	Dement Geriatr Cogn Disord2000，11，2：	1
9	Physiopathology of H3-receptors and pharmacology of betahistine 显示文摘	Van Cauwenberge PB De Moor SE	1997	Acta Otolaryngol Suppl1997，526，：	1
10	Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase Ⅱ studies显示文摘	Bays HE Moore PB Drehobl MA	2001	Clin Ther2001，23，：	1
11	Strain typing and antimicrobial resistance of fluomquinolone-resistant Neisseria gonor- rhoeae causing a California infection outbreak 显示文摘	Morris SR Moore DF Hannah PB	2009	J Clin Microbiol2009，47，9：	1
12	Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase Ⅱ studies 显示文摘	Bays HE Moore PB Drehobl MA	2001	Clin Ther2001，23，8：	1
13	Understanding nature's design for nanosyringe显示文摘	Lopez CF Nielsen SO Moore PB	2004	Proc Natl Acad Sci USA2004，101，13：	1
14	Physiopathology of H3- receptors and pharmacology of betahistine显示文摘	Van Cauwenberg PB De Moor SEG	1997	Acta Otolaryngol1997，526，：	1
15	Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia:pooled analysis of two phase Ⅱ studies显示文摘	Bays HE Moore PB Drehobl MA	2001	Clin Ther2001，23，：	1
16	Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase Ⅱ studies显示文摘	Bays HE Moore PB Orehobl MA	2001	Clin Ther2001，23，5：	1
17	Physiopathology of H3-receptors and pharmacology of Betahistine显示文摘	De Moor SEG	1997	Acta Otolaryngol (Stockh)1997，，：	1
18	Synthesizing Eu2+activated stroriam aluminate phosphor显示文摘	MOORE PB Victor A		0，，：	1
19	Physiopathology of H3-receptors and pharmacology of Betahistine显示文摘	De Moor SEG	1997	Acta Otolaryngol(Stockh)1997，，：	1
20	Absorption of al uminium-26 in Alzheimer's disease,measured using accelerator mass spectrometry显示文摘	Moore PB Day JP Taylor GA	2000	Dement Geriatr cogn Disord2000，11，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示